Abstract
Epstein–Barr virus (EBV) is associated with the development of lymphoproliferative disorders in the immunocompromised host and in particular post-transplant recipients. The development of a rapid real-time quantitative PCR for the detection of the immediate early gene BZLF1 is described using the Roche LightCycler. BZLF1 codes for the ZEBRA protein, one of the cascade of transactivation factors involved in the lytic life cycle of the virus. The assay is rapid and can detect a single copy of EBV DNA. Intra- and inter-assay variability studies using the external quantitative standards and DNA extracted from whole blood and plasma samples were shown to be within a 0.5 log 10 range.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
